ABSTRACT X-linked retinoschisis (XLRS) is an inherited form of macular degeneration that is caused by mutations in the retinoschisin (RS1) gene. In addition to macular degeneration, other major characteristics of XLRS include splitting of the retina (schisis) and impaired synaptic transmission as indicated by a reduction in the electroretinogram b-wave. It has been known that patients carrying RS1 mutations show a broad range of phenotypic variability. Interestingly, phenotypic variation is observed even among family members with the same RS1 mutation, suggesting the existence of genetic or environmental factors that contribute to the severity of XLRS. However, in the human population, the cause of phenotypic variability and the contribution of genetic modifiers for this relatively rare disease are difficult to study and poorly understood. In this study, using a mouse model for XLRS, we show that genetic factors can contribute to the severity of the retinoschisis phenotype. We report evidence of a major genetic modifier of Rs1, which affects the disease severity in these animals. A quantitative trait locus (QTL), named modifier of Rs1 1 (Mor1), is mapped on chromosome (Chr) 7. When homozygous, the Mor1 allele from the inbred mouse strain AKR/J diminishes the severity of the schisis phenotype in Rs1 tmgc1 /Y male and Rs1 tmgc1 /Rs1 tmgc1 female mice. We also show that the penetrance of the disease phenotype is affected by additional genetic factor(s). Our study suggests that multiple genetic modifiers could potentially be responsible for the phenotypic variation in human XLRS.
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tmgc1 female mice. We also show that the penetrance of the disease phenotype is affected by additional genetic factor(s). Our study suggests that multiple genetic modifiers could potentially be responsible for the phenotypic variation in human XLRS.
X -LINKED retinoschisis ½XLRS; Online Mendelian
Inheritance in Man (OMIM) 312700 is a juvenile form of macular degeneration that affects male children with an incidence of 1 in 5000 to 1 in 25,000 (George et al. 1995b) . XLRS is characterized by foveal schisis (splitting of the central retina), degeneration of the vitreous and retina, and reduced synaptic transmission characterized by a reduction in the electroretinogram (ERG) b-wave (Peachey et al. 1987; George et al. 1996; Retinoschisis Consortium 1998; Seiving 1998 ). Roughly 50% of XLRS patients have peripheral retinoschisis (Roesch et al. 1998; Pimenides et al. 2005) .
XLRS is caused by mutations in the RS1 gene (formerly RS; Sauer et al. 1997) . Over 150 allelic variants of RS1 mutations have been identified to date (X-Linked Retinoschisis Sequence Variation database at http:/ /www. dmd.nl/rs/). XLRS patients exhibit a broad range of phenotypic severity. For example, the maculopathy observed in patients ranges from foveal radial striations and microcystic macular lesions to large atrophic macular lesions (Harris and Yeung 1976; Roesch et al. 1998) . Other complications observed in some patients include retinal detachment, vitreous hemorrhage, nystagmus, and neovascular glaucoma (Kellner et al. 1990; Pimenides et al. 2005) . Specific mutations have not been found to correlate with phenotypic severity (Shinoda et al. 1999; Eksandh et al. 2000; Hiraoka et al. 2000; Nakamura et al. 2001; Simonelli et al. 2003; Hewitt et al. 2005; Pimenides et al. 2005) . Even family members with the same mutation exhibit large variation in phenotypic severity (Eksandh et al. 2000; Pimenides et al. 2005) . This large intrafamilial and interfamilial phenotypic variation suggests the existence of genetic modifiers or differential susceptibility to environmental factors.
Human RS1 is composed of 6 exons encoding the 224-amino acid protein, retinoschisin (RS1) (Sauer et al. 1997) . The expression of RS1 has been detected in the retina (Sauer et al. 1997 ) and the pineal gland (Takada et al. 2006) . In the retina, RS1 is synthesized in the photoreceptor cells (Reid et al. 1999 ) and other retinal neurons (Molday et al. 2001; Weber et al. 2002; Takada et al. 2004) . The 24-kDa protein contains an N-terminal leader sequence which is cleaved for secretion, an RS1 domain that is important for higher order structure (Wu and Molday 2003) , and a highly conserved discoidin domain. The discoidin domain is the major feature of RS1, comprising .75% of the processed protein (Sauer et al. 1997) . Discoidin domains are found in a wide range of proteins involved in cell adhesion and cell-cell interactions, implicating RS1 in retinal cell adhesion (Baumgartner et al. 1998) . Once processed, RS1 assembles into a disulfide-linked homooctamer (Wu et al. 2005) . Recently, it was shown that RS1 interacts with a Na/K ATPase-SARM1 complex to anchor 1 to the photoreceptor and bipolar cell membrane (Molday et al. 2007) . However, the manner by which RS1 mediates cell adhesion remains to be determined.
Two gene-targeted mutants (Weber et al. 2002; Zeng et al. 2004 ) and one ENU-induced splice-site mutant (Jablonski et al. 2005a) have been generated in the murine RS1 homolog, Rs1. These mutant mice have phenotypes similar to human XLRS patients such as b-wave loss, photoreceptor cell degeneration, and schisis (Weber et al. 2002; Zeng et al. 2004; Johnson et al. 2006) , showing that the mouse can serve as a model to study XLRS. Research on XLRS mouse models has also identified phenotypes that cannot be easily studied in human patients. Previously, we showed that the splicesite mutant, 44TNJ (Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y), has reduced synaptic vesicle density in the photoreceptor cells and ectopic synaptic localization in the outer retina ( Johnson et al. 2006) . In studies using Rs1 À /Y gene targeted mice, gene therapy has been shown to restore the b-wave loss Min et al. 2005) . Further studies in these mouse models may provide key insights into the pathological mechanisms and treatment of human XLRS.
Modifier screening allows for the identification of loci that interact with a primary Mendelian trait or disease of interest (reviewed in Nadeau 2001 Nadeau , 2003 . The heterogeneous nature of human populations and the variability of possible environmental influences make modifier screening in humans difficult. To overcome this challenge, modifier screens in mouse models can be used to identify modifiers in genetically homogeneous populations and controlled environments. A genetic modifier that is identified in the mouse can then be tested for its affect on disease in humans. As an example, a modifier of obesity-induced type 2 diabetes, Sorcs1, originally identified in the mouse (Clee et al. 2006) was recently linked to diabetes susceptibility in humans (Goodarzi et al. 2007) . A modifier of mammary tumor susceptibility, deleted in malignant brain tumors 1 (Dmbt1), was also originally identified in the mouse and then linked to mammary tumor susceptibility in humans (Blackburn et al. 2007) . These examples illustrate that modifier screening in the mouse provides a powerful tool to identify modifiers of human disease.
In this study, we report the identification of a major quantitative trait locus (QTL), named modifier of Rs1 1 (Mor1). The AKR protective allele of the Mor1 locus restores cell adhesion in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mutant mice when homozygous. This report marks the first evidence that genetic modifiers influence the disease severity in Rs1 mutant mice and suggests similar genetic factors may influence XLRS disease severity. /Y (n ¼ 6), and 4-and 9-week-old B6 wild-type (n ¼ 6, n ¼ 5, respectively) mice as previously described (Pinto et al. 2004) . Briefly, mice were dark-adapted for at least 2 hr prior to recording and all procedures were performed in total darkness. After being anesthetized with ketamine (70 mg/kg) and xylazine (7 mg/kg), mice were placed in the recording chamber on a heating pad to maintain body temperature at 37°. Mice were fitted with DTL fiber electrodes on each eye and the electroretinogram recorded differentially between the eyes. After the corneas were moistened with 0.9% NaCl, one eye was covered with a clear contact lens and the other with an opaque contact lens. Nine full-field flash stimuli ½luminance 7 3 10 À4 to 300 candela (cd) sec/m 2 were presented to the eye covered with the clear lens against a dark background and a dim adapting light (0.5 cd/m 2 ) was presented steadily to light-adapt the retina while a flash stimulus (luminance 0.2 cd sec/m 2 ) was presented to evoke the cone electroretinogram. Electroretinograms were differentially amplified (0.1-1000 Hz) and recorded at 1 kHz with a resolution of 0.5 mV. The amplitude of the a-wave was measured from the prestimulus baseline to the peak of the a-wave. The amplitude of the b-wave was measured from the peak of the a-wave to the peak of the b-wave, or from the prestimulus baseline if no a-wave was present. All data in the luminance series were analyzed by a two-way analysis of variance (ANOVA) using GraphPad Prism software (GraphPad, San Diego). The b/a-wave ratios were analyzed by one-way ANOVA.
MATERIALS AND METHODS

Congenic
QTL and statistical analysis: We performed an initial whole genomewide scan using 45 Rs1 tmgc1 /Y F 2 intercross mice. We selected 80 microsatellite markers that distinguish both B6 and C3H alleles from AKR alleles across the whole genome. All F 2 animals were phenotyped by histological analysis irrespective of genotyping. Affected animals were independently scored by four people in a semiquantitative fashion. The four observers' scores were averaged to reduce human error. Scores ranged from zero to two (from wild type to severe, respectively) for schisis ( Figure 2 ). QTL analysis was performed using the R/qtl statistical package (http:/ /www.rqtl.org/) (Broman et al. 2003) . To calculate LOD scores, R/qtl first generated a genetic map on the basis of the data of our cross. LOD scores were calculated using the multiple-imputation method (Sen and Churchill 2001) with 1-cM steps, 1000 joint genotype distribution imputations, and an assumed genotyping error rate of 0.01. To determine the significance of the results, a permutation test with 1000 replications was used. After the initial linkage on Chr 7 was determined, 225 additional Rs1 tmgc1 /Y F 2 mice were phenotyped and genotyped for Chr 7 markers. QTL analysis was then performed on all 270 mice. For comparing the phenotypic distribution of the different F 2 genotypes ( Figure 3 ) and the B6 congenic genotypes ( Figure  4 ), one-way ANOVA with Bonferroni correction was calculated using GraphPad Prism software (GraphPad). To compare the penetrance of the schisis phenotype between the B6 and C3H congenic lines ( Figure 5 ), GraphPad Prism software (GraphPad) was used to generate a 2 3 2 contingency table and calculate the resulting x 2 -value. Quantifying the ratio of differentially spliced transcripts from Rs1: Total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA) from one retina of 4-week-old Rs1
Three hundred fifty nanograms of total RNA from each sample were converted to cDNA using the Superscript III first-strand synthesis system (Invitrogen) according to the manufacturer's instructions. Each sample was amplified in triplicate for the Rs1 gene. A detailed protocol for RT-PCR and primer sequences were previously described ( Johnson et al. 2006) . After amplification, RT-PCR products were dried in a speed-vac concentrator and resuspended in 2 ml of water. One microliter of product was separated for fragment analysis on an Agilent 2100 bioanalyzer with a DNA 7500 kit according to the manufacturer's instructions (Agilent Technologies, Palo Alto, CA). Fragment analysis was conducted using samples collected after every 2 cycles between 20 to 30 cycles. The data presented here are for samples where amplification was in the linear range. Time-corrected areas of fragments were used to calculate the transcription ratio. Oneway ANOVA and Tukey's multiple-comparison tests were conducted using GraphPad Prism software (GraphPad). All four fragments were sequenced at the University of Wisconsin Biotechnology Center for sequence confirmation. /Y mice carry a point mutation in the splice donor site of exon 2 in the Rs1 gene ( Jablonski et al. 2005a) . These mice are maintained on a mixed background of B6 and C3H. In a previous study, we reported the appearance of the schisis phenotype in these mice by postnatal day (P) 19 ( Johnson et al. 2006) . In this report, we studied the time course of structural changes in the retina of Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice and found that the phenotypes in these mice are the most severe at $4 weeks of age. Three major morphological phenotypes were observed in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice at 4 weeks of age: schisis of the inner nuclear layer (INL), waving of the outer nuclear layer (ONL), and ectopic nuclei in the photoreceptor segment layers ( Figure 1A) . We found that these phenotypes become milder as the mice age. By 10 weeks of age, the schisis phenotype has disappeared but mild layer disorganization is still observed ( Figure 1A) .
RESULTS
Retinal phenotypes of
To study the relationship between schisis and retinal function, we also performed ERG analysis at 4 and 9 weeks of age. The ERG a-wave represents the function of the photoreceptor cells while the b-wave is a measure of postsynaptic bipolar cell activity. Mice were studied under dark-adapted conditions to examine the rod pathway. /Y mice from 4 to 9 weeks of age ( Figure 1B ; ANOVA, P , 0.0001). This decrease is likely due to slow photoreceptor cell degeneration or functional loss. In contrast, the amplitude of the b-wave tends to be slightly higher at 9 weeks of age than at 4 weeks of age in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice, although the difference does not reach statistical significance ( Figure  1B ). Since the b-wave is measured from the trough of the a-wave to the peak of the b-wave, a decrease in the a-wave amplitude would result in a decrease in the b-wave amplitude. To counteract this effect and to better represent the function of the b-wave generating mechanisms, we calculated the b/a-wave ratio to normalize for the decrease in a-wave that occurs in 9-week-old Rs1 /Y compared to wild type (ANOVA, P , 0.0001; Figure 1C) . The b/a-wave ratio in 9-week-old Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice, however, is comparable to that in wildtype mice ( Figure 1C) . The b/a-wave ratio has significantly improved in 9-week-old mutant mice compared to 4-week-old mutant mice (ANOVA, P , 0.0001; Figure  1C ). These results suggest that the b-wave generating mechanisms in 9-week-old Rs1 Figure 1A ). Figure 2 shows representative phenotypes in the F 2 population, demonstrating the large phenotypic variation, along with the semiquantitative score (schisis index) given to each. All Rs1 tmgc1 /Y F 2 mice that were phenotyped by histological analysis were also genotyped using microsatellite markers distributed across the entire genome. One major QTL with a large effect was found on Chr 7 (LOD ¼ 6.31, P , 0.001) ( Figure 3A) . Additional markers and animals were used to define the region encompassing the significantly linked QTL on Chr 7. Marker D7Mit321 was most highly associated with the schisis index (LOD ¼ 17.2, P , 0.0001, 3 LOD support interval ¼ 46.1-55.1 cM) ( Figure 3B ). The AKR allele of this QTL significantly reduced the schisis index in Rs1 tmgc1 /Y mice in a recessive fashion ( Figure 3C) ; at least one copy of either the B6 or the C3H allele renders the mice susceptible for the schisis phenotype ( Figure 3D ). We named the gene responsible for this QTL, the Mor1 gene. /Y (data not shown), which has a mixed genetic background of B6 and C3H ( Jablonski et al. 2005a /Y mice (mixed genetic background of B6 and C3H), we generated a second congenic line on a C3H genetic background, C3H.Cg-Rs1 tmgc1 and tested the appearance of the schisis phenotype at P30. We observed that 92% (n ¼ 12/13) of C3H.CgRs1 tmgc1 mice (N 5 -N 9 generations) show the schisis phenotype ( Figure 5 ). This is in contrast to the phenotypic distribution of B6.Cg-Rs1 tmgc1 mice (N 5 -N 9 generations) shown in Figure 5 , in which only 37% (n ¼ 14/38 total) of the B6. Figure 6A ). On the basis of our previous study to sequence subclones of RT-PCR products, the B6 retina appears to have a single wildtype transcript ( Johnson et al. 2006) . In contrast, at least three alternative transcripts in mice carry a mutation in the Rs1 gene including Rs1 
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tmgc1 mice at 16 weeks of age, the percentage of wild-type transcripts was $30% of the total, transcripts with exon 2 deleted were $41%, and transcripts with exons 2 and 3 deleted were $22% (Figure 6C) . Transcripts with intronic retention were $7% in all mutant lines at 4 weeks of age ( Figure 6C) 
DISCUSSION
In this study, we show that genetic factors are important to determine the severity and penetrance of XLRS phenotypes observed in Rs1 mutant mice. 
Rs1 tmgc1
/Y F 2 mice showed a wide range of phenotypic severity, indicating the existence of genetic factors that affect these phenotypes. We identified a major QTL named Mor1, which is a single locus that acts as a recessive suppressor for the schisis phenotype. The protective (AKR) allele of Mor1, when homozygous, restored cell adhesion in B6.Cg-Rs1 tmgc1 Mor1 AKR mice. Our results also suggest that an allelic difference in the genetic background between B6 and C3H affects the penetrance of the retinoschisis phenotype.
Mor1 is a major QTL: It has been hypothesized that RS1 is involved in cell adhesion on the basis of its /Y F 2 mice. After Mor1 was identified in the whole genome scan, 225 additional mice were genotyped and phenotyped for Chr 7. The LOD score distribution for the total 270 Rs1 tmgc1 /Y F 2 intercross mice is shown. The genetic map was generated in R/qtl on the basis of our cross. D7Mit321 is the marker that is closest to the peak LOD score of 17.2 (P , 0.0001). Three horizontal lines represent significant linkage as noted in A. (C) Phenotypic distribution of F 2 mice at D7Mit321. Error bars represent 61 standard error. 44TNJ includes both B6 and C3H alleles. (D) Mean schisis index of Rs1 tmgc1 /Y F 2 mice with respect to AKR, B6, and C3H alleles. B6 and C3H alleles render the severe phenotype. Only mice that are AKR/AKR at D7Mit321 show significant reduction of the schisis index (ANOVA, P , 0.0001).
localization at the cell surface and schisis-like phenotypes in both human XLRS patients and in mouse models carrying Rs1 gene mutations (Sauer et al. 1997; Retinoschisis Consortium 1998; Weber et al. 2002; Zeng et al. 2004; Wu et al. 2005; Molday et al. 2007; Vijayasarathy et al. 2007 ). Our results show that a single locus, Mor1, can specifically modify cell adhesion and other retinal phenotypes in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice. The effect of the allelic difference of the Mor1 gene on maintenance of cell adhesion is not observed in wild-type mice, however, the allelic effect becomes significant when RS1 does not function properly. This finding suggests an epistatic interaction between Rs1 and Mor1.
Possible roles of MOR1: The protective allele of Mor1 may restore cell adhesion in Rs1 /Y retinas, 30% of Rs1 transcripts are normally spliced. MOR1 may be able to specifically interact with the normal RS1 and enhance its function in the diseased retina or MOR1 may be able to directly replace RS1 when RS1 is nonfunctional. MOR1 could also function in a parallel pathway involved in cell adhesion that, when in the presence of a mutant RS1, is upregulated and can compensate for the loss of RS1-mediated cell adhesion.
Alternatively, we hypothesize that MOR1 may affect the population of transcripts in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y retinas. Rs1 tmgc1
/Rs1
tmgc1 and Rs1 tmgc1 /Y mice harbor a T-to-C point mutation in the splice donor site of exon 2 ( Jablonski et al. 2005a) . The mutation causes aberrant splicing which leads to transcripts with skipped exons or cryptic splice sites ( Johnson et al. 2006) . Nevertheless, $30% of the Rs1 transcripts are spliced normally. We hypothesized that MOR1 could be a part of the splice machinery, in which case the AKR variant of MOR1 could increase the proportion of correctly spliced Rs1 products. Recently in another mouse model of disease, it was reported that a splice-site variant modifies disease severity (Howell et al. 2007) . The B6 variant of the sodium channel modifier 1 (SCNM1), an RNA splicing factor, has been shown to modify disease severity in Scn8a med/J mice (Buchner et al. 2003; Howell et al. 2007) . After performing the fragment analysis (Figure 6 ), however, it is unlikely that Mor1 is involved in RNA splicing. Mice were tested at 4 weeks of age unless noted. The ratios for wild-type transcripts, transcripts that skip exon 2, and transcripts that skip both exons 2 and 3 are not significantly different among all groups tested. The ratio of wild-type transcripts with intronic sequence is significantly different (P , 0.05) between Mor1 Natural rescue: In Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice (the original strain of mice that are not homozygous for the protective allele of Mor1), we consistently observe restoration of cell adhesion by 10 weeks of age ( Figure  1) . A compensatory pathway involved in cell adhesion may turn on naturally in aged Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice that rescues the schisis phenotype. It is possible that MOR1 may be involved in both restoration of cell adhesion at an early age (P30) and natural rescue at an older age. For example, the AKR allele of Mor1 could contain a polymorphism in the Mor1 promoter region, which causes Mor1 expression to be turned on at a younger age. This natural schisis rescue has also been reported in a knockout model of Rs1 (Kjellstrom et al. 2007) . The time course of rescue is different in knockout mice, which show the most severe phenotypes at 4 months of age (Kjellstrom et al. 2007 ) whereas phenotypes in Rs1 tmgc1 /Rs1 tmgc1 and Rs1 tmgc1 /Y mice are most severe at 4 weeks of age. Nevertheless, the same molecular mechanism for rescuing schisis may be shared by the two mouse strains. In human XLRS patients, natural improvement of disease phenotypes over time (such as spontaneous reattachment and increased visual acuity) have also been reported (George et al. 1995a (George et al. ,b, 1996 Apushkin et al. 2005) .
Candidate genes: Genes that are expressed in the retina and known to be involved in cell adhesion could be candidates for Mor1. Although the minimal genetic region of Mor1 is still large (9 cM on the basis of our genetic map, which is encompassed in the region between D7Mit279 and D7Mit237, $635 annotated genes), preliminary examination of the Mor1 region identifies some interesting candidate genes. Genes that encode transmembrane, membrane-associated, extracellular matrix proteins, or proteins involved in synaptic stability are attractive candidates for Mor1. For example, discs large homolog 2 (Dlg2), located between markers D7Mit62 and D7Mit321, encodes a scaffolding protein involved in stabilization of cholinergic synapses (Parker et al. 2004) . Other genes within the Mor1 region that encode transmembrane proteins, membrane-associated proteins, or extracellular matrix proteins include transmembrane proteins 126, a and b (Tmem126a and Tmem126b), transmembrane protein 135 (Tmem135), odd Oz/ten-m homolog 4 (Odz4), tsukushin (Tsku), and frizzled homolog 4 (Fdz4).
Genetic variability is the cause for differences in the penetrance of the schisis phenotype in Rs1 tmgc /Rs1 tmgc1 and Rs1 tmgc1 /Y mice: We found that C3H.Cg-Rs1 tmgc1 mice have a higher penetrance of the schisis phenotype than B6.Cg-Rs1 tmgc1 mice ( Figure 5 ). From these results we hypothesize that there may be another modifier(s) that affects the penetrance of the schisis phenotype. Since F 2 mice with either B6 or C3H across Chr 7 have the severe phenotype ( Figure 3D ), this second modifier is most likely not on Chr 7. The original Rs1 tmgc1 (44TNJ) line may always have the severe phenotype because the majority of the genetic background in these mice is C3H. Similar genetic background effects on the penetrance of phenotypes have been previously reported (reviewed in Nadeau 2001). For example, the penetrance of the multiple birth defects caused by the disorganization (Ds) mutation ranges from 89% penetrance on a C3H background to as low as 0% on a B6 background (Hummel 1958) . It has been hypothesized that environmental factors such as diet and light may affect the phenotypic variability observed in Rs1 knockout mice (Kjellstrom et al. 2007) . The results of our study suggest that genetic factors also have a major effect in the appearance of the retinoschisis phenotype. It is possible that these genetic factors may interact with some environmental factors, thereby changing the susceptibility to the environment.
Relevance to human XLRS: In human XLRS patients, there is large variability in the severity of phenotypes caused by a particular RS1 mutation. Numerous cases have been documented where family members with the exact same RS1 mutation have a wide range of phenotypic severity, which suggests the existence of genetic modifiers (Eksandh et al. 2000; Pimenides et al. 2005) . Searching for modifiers in humans is challenging due to heterogeneous genetic backgrounds. The mouse provides a powerful tool to search for and identify modifier genes. Following the identification of modifier genes in mice, the same modifiers can be examined in human patients. Mor1 is the first modifier of Rs1 identified to date. Identification of the causative gene of Mor1 will not only provide insight into the function of RS1, but may also provide insight into the genotypephenotype disparity observed in human XLRS patients and elucidate novel therapeutic approaches for XLRS.
